BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously

RBC Capital Mkts initiated coverage of Concentra Group Holdings Parent with a rating of Outperform and set a new price target of $33.00

BofA Securities initiated coverage of Concentra Group Holdings Parent with a rating of Buy

Deutsche Bank initiated coverage of Concentra Group Holdings Parent with a rating of Buy and set a new price target of $29.00

JP Morgan initiated coverage of Concentra Group Holdings Parent with a rating of Overweight and set a new price target of $29.00

Goldman initiated coverage of Concentra Group Holdings Parent with a rating of Buy and set a new price target of $32.00

Mizuho initiated coverage of Concentra Group Holdings Parent with a rating of Outperform and set a new price target of $28.00

Wells Fargo initiated coverage of Concentra Group Holdings Parent with a rating of Overweight and set a new price target of $27.00

Truist initiated coverage of Concentra Group Holdings Parent with a rating of Buy and set a new price target of $29.00

SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

MECHANICSBURG, Pa., Nov. 19, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced the distribution ratio for the previously announced special stock distribution (the "Distribution") to its stockholders of its equity interest in Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON). Based on the shares of Select Medical's common stock outstanding as of November 18, 2024, the record date (the "Record Date") for the Distribution, Select Medical's stockholders will receive 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the close of business on the Record Date.

Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in DeSoto, Texas. The medical center, Concentra DeSoto, is conveniently located at 1111 North Interstate 35 E, DeSoto, Texas 75115. "We're excited to grow our footprint in the Dallas-Fort Worth Metroplex," said Robert Hassett, DO, MPH, senior vice president of Concentra medical operations. "Our new DeSoto location will open up a new avenue for care for employers in southwest Dallas." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services from its new location in DeSoto.

MECHANICSBURG, Pa., Nov. 6, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that its Board of Directors has approved a special stock distribution (the "Distribution") to Select Medical's stockholders of the 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. The Distribution by Select Medical of the special stock distribution will be made on November 25, 2024 (the "Distribution Date") to all

Concentra Group Holdings Parent, Inc. ("Concentra," "we," "us," or "our") (NYSE:CON) today announced results for its third quarter ended September 30, 2024, and the declaration of a cash dividend. "We had a successful quarter and made significant progress on key strategic initiatives and our separation from Select Medical. I am proud of our results, solid execution, and our colleagues' continued dedication to delivering quality patient-centric care," said Keith Newton, Chief Executive Officer of Concentra. Matt DiCanio, President & Chief Financial Officer, added "We expanded our footprint in new and existing areas and achieved some of our highest patient satisfaction scores. With our robu

Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Orlando, Florida. The medical center, Concentra Orlando West, is conveniently located at 6708 Grand National Drive, Orlando, Florida 32819. "We're excited to grow our footprint in Orlando," said Janet Cobb, MD, senior vice president of Concentra medical operations. "We have strong relationships with the employers in the area and look forward to offering them another access point for care." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services from its new location i

Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2024, on Thursday, October 31, 2024, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 1, 2024, at 10:30 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: To

Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Chattanooga, Tennessee. The medical center, Concentra Chattanooga Airport, is conveniently located at 6413 Lee Highway, Suite 107, Chattanooga, Tennessee 37421. "Chattanooga is a new area for us, and we're excited for the opportunity to serve the city's employers," said Janet Cobb, MD, senior vice president of Concentra medical operations. "We look forward to further expanding in the greater Knoxville area later this year." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related heal

Concentra® (NSYE: CON), the nation's leader in occupational medicine, has expanded its Onsite Health division's suite of services to include advanced primary care. This offering will serve as a solution for employers seeking ways to lower health care costs and improve medical outcomes while streamlining participants' health care access. With this expansion, Concentra Onsite Health will enter a new era of employer-sponsored health and wellness services. "Concentra's approach to advanced primary care supports employers in their efforts to establish and sustain a culture of health and wellness among their employee population," said Mike Rhine, Concentra executive vice president and chief oper

Concentra Group Holdings Parent, Inc. ("Concentra," "we," "us," or "our") (NYSE:CON) today announced results for its second quarter ended June 30, 2024. "Our colleagues' ongoing commitment to providing exceptional service and care continues to be the powerful force driving Concentra forward. With steadfast dedication to our mission to improve the health of America's workforce, one patient at a time, we have reached another important milestone with the completion of our IPO," said Keith Newton, Chief Executive Officer of Concentra. Matt DiCanio, President & Chief Financial Officer, added "We are so proud of our colleagues and teams who have provided great care and dedication over the pas